Jan. 11, 2023
Canadian physicians have successfully used an MRI-guided ultrasound to deliver chemotherapy to an inoperable brain tumour in a child – a world-first for this type of technology.
It’s the start of a groundbreaking clinical trial at Sunnybrook Health Sciences Centre and Toronto’s Hospital for Sick Children that researchers and doctors are hoping could open the door to better treat terminal paediatric tumours.
The procedure was performed on a patient with diffuse intrinsic pontine glioma (DIPG), which is the most common form of brain tumour in children under the age of 15.
“DIPG is a devastating pediatric brain tumour which is inoperable due to its location in the brainstem,” Dr. Nir Lipsman, study co-principal investigator and director of Sunnybrook’s Harquail Centre for Neuromodulation, said in a press release.